openPR Logo
Press release

Active Pharmaceutical Ingredients Market 2018 Global Analysis, Opportunities And Forecast To 2023

07-15-2019 02:54 PM CET | IT, New Media & Software

Press release from: Market Research Future

/ PR Agency: Market Research Future
WEPK7K

WEPK7K

Active Pharmaceutical Ingredients Market Expected to Witness a Steady Rise

The drugs that we use, such as tablets, injectables, syrups, and capsules) are an amalgamated combination Active Pharmaceutical Ingredients (API) and excipients. It is a chemical or a drug which is responsible for the therapeutic and pharmacological activities in the human body. It is the most important ingredient in a drug that helps treat a disorder or a disease when administered. It is a substance that is integrated into a Finished Pharmaceutical Product (FPP). As per Market Research Future’s in-depth analysis of the global Active Pharmaceutical Ingredient (API) market, the growth trajectory of the market is projected to remain positive with a CAGR of 4.93% over the next five years of the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1385

APIs have gone on to become an integral component in the healthcare industry, primarily because of the clinical efficacy and value it offers. The development of advanced delivery systems coupled with the emergence of novel therapeutics is expected to expand the market opportunities of APIs in the forecast period. There also lies the growing trend concerning personalized medicines which can also influence the market landscape of APIs. The other factors driving the growth of the active pharmaceutical market are increased focus towards curbing down the pricing of manufacturing and supply chain consolidation.

Market Segmentation

The segmentation of the global Active Pharmaceutical ingredient market is based in terms of manufacturing process, application, API Formulation, type of synthesis, and molecules.

Manufacturing Basis: The market comprises of captive and contract manufacturing. The captive manufacturing segment holds the largest market share and is expected to maintain its hold in the forthcoming years.

Application Basis: The market includes neurological disorders, gastrointestinal disorders, orthopedic disorders, oncology, respiratory, urology, cardiovascular disease, and others. The oncology segment is projected to experience the fastest growth among all.

API Formulation Basis: The market covered are generic API and Innovative API. The generic API segment is the leading market player.

Type of Synthesis: The market is divided into synthetic and biotech.

Molecules Basis: The market is segmented into large molecules and small molecules.

Regional Outlook

The key markets for active pharmaceutical ingredients include South America, Europe, Asia Pacific, North America, and the Middle East & Africa.

North America is spearheading the API market growth in the Americas, which in turn is leading the global market with the largest share. The crucial factors backing the said growth include the presence of a large number of prominent companies within the region. In addition, countries like the United States (U.S.) and Canada note high occurrences of chronic as well as neurological diseases, which is believed to be a prominent driver of the regional market growth.

Europe has bagged the second spot in the global API market, backed by the increasing number of initiatives within the region that support the development of generic drugs. Moreover, improving pricing, as well as reimbursement policies coupled with a huge number of manufacturing activities, is presenting multiple growth opportunities to the regional market.

As the active pharmaceutical ingredients market has reached the maturity phase in the developed countries around the globe, the market focus is shifting towards the Asia Pacific. This factor has substantiated the region as the fastest-growing market globally. The presence of a humungous patient population within countries like India and China paired with the rising incidences of chronic diseases in the region is poised to benefit the market in the subsequent years. On top of that, availability of cheap labor and need for low investments in infrastructure are encouraging several renowned pharmaceutical vendors to outsource manufacturing to Asia Pacific, opening the door for further market success.

Competitive Analysis

The key companies identified in the global Active Pharmaceutical Ingredients Market are Merck & Co., Inc., GlaxoSmithKline Plc (GSK), F. Hoffmann-La Roche AG, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Pfizer Inc., Teva Pharmaceutical Industries Ltd. Bayer AG, and Sanofi.

On Feb 2019, ProvideGx, LLC, a subsidiary company of Premier Inc. which provides healthcare improvement services, announced its collaboration with Baxter Healthcare Corporation. The move is aimed to make additional generic drugs available to counter the rising drug shortage issue in the US.

On Feb 2019, TPG Growth, a private equity firm, revealed its plans of investing $30 million in Solara Active Pharma. The funding will help support the Chennai-based drug manufacturer, Solara Active Pharma, spread its wings of expansion in the regulated markets.

Read More @ https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

WantStats Research and Media Pvt. Ltd. Office No. 528
Amanora Chambers

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Active Pharmaceutical Ingredients Market 2018 Global Analysis, Opportunities And Forecast To 2023 here

News-ID: 1803579 • Views: 140

More Releases from Market Research Future

Reusable Satellite Launch Vehicle (RSLV) Market 2019-2023 | Report Information b …
Global Reusable Satellite Launch Vehicle Market Report Information by Configuration (Single Stage, Multiple Stage), by Type (Partially Reusable, Fully Reusable), Vehicle Weight (Up to 4,000lbs, 4000-9000lbs, Over 9000lbs), & by Region - Forecast Till 2023 The Reusable satellite launch vehicle market is estimated to witness a CAGR of more than 12% during the forecast period from 2018 to 2023. The key players in the reusable satellite launch vehicle market are Airbus S.A.S
Bakery Enzymes Market Global Research Report and Top Key Players: AB Enzymes Gmb …
Market Overview The increasing demand for bakery products in the food and beverage industry including, bread, cookies, and pastries are raising the demand for bakery enzymes at a global level. Enzymes are an important ingredient used in most bakery products. There are two scenarios regarding the use of enzymes, either the enzymes are used to convert the raw material into the main product, or the enzymes are used as additives to
Commercial Airport Lighting Market 2019-2023 | Worldwide Overview By Technology, …
Global Commercial Airport Lighting Market Research Report: Information by Technology (LED, Non-LED), by Application (Airside Lighting, Terminal Lighting, Landside Lighting), and by Region — Forecast till 2023 Honeywell International Inc., (US), ADB SAFEGATE (US), ABB (Switzerland), vosla GmBH (Germany), Avlite (Australia), Carmanah (Canada), Eaton (Ireland), atg airports limited (UK), Avionics Group (US), and HELLA GmBH & Co. KGaA (Germany) are some of the prominent players profiled in MRFR Analysis and are
Dairy By Products Market 2019-2023 | Global Top Key Player Review: Nestle S.A. ( …
Dairy By-Products Market – Overview The escalation in the level of dairy production has increased the supply of dairy by-products significantly. Market reports associated with the Food, Beverages & Nutrition industry have been made available by Market Research Future who publishes reports on other sectors that have been presently published along with a report on this industry. The market is set to expand at a positive CAGR rate in the forecast

All 5 Releases


More Releases for API

Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our